Your position:
m.limatoxi.com
>>
EN
>>
EN
>>
Formulation
>>
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis
>> article
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis
Editor:xuezhe Clicks:
0
Date:2024-6-7 17:22:12
Keyword:
US FDA
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
US EPA, US FDA & USDA issue joint regulatory plan for biotechnology
What products does Xinhe New Synthetic Bio-industrial Base project hav...
Golden corn bio-based new material industrial park 200,000 tons of ami...
Global API industry: Trends, opportunities & challenges
Common pharmaceutical industry: the price inflection point of steroid ...
Novartis Acquires FDA Priority Review Voucher from bluebird bio for Times="10"...
The vitamin industry has entered the downward running-in period after ...
Cellulose Ether Market Analysis: Pharmaceutical Industrys Growth Trend
Nine key words & hot events in the pharmaceutical industry in 2023 H1
Multiple product indications withdrawn, FDA accelerated Approval How t...
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
